[go: up one dir, main page]

PE20001019A1 - Nueva membrana o matriz para controlar la penetracion de farmacos - Google Patents

Nueva membrana o matriz para controlar la penetracion de farmacos

Info

Publication number
PE20001019A1
PE20001019A1 PE1999001124A PE00112499A PE20001019A1 PE 20001019 A1 PE20001019 A1 PE 20001019A1 PE 1999001124 A PE1999001124 A PE 1999001124A PE 00112499 A PE00112499 A PE 00112499A PE 20001019 A1 PE20001019 A1 PE 20001019A1
Authority
PE
Peru
Prior art keywords
siloxane
substituted
trifluoropropyl
groups
poly
Prior art date
Application number
PE1999001124A
Other languages
English (en)
Inventor
Jarkko Ruohonen
Matti Lehtinen
Harri Jukarainen
Tommi Markkula
Juha Ala-Sorvari
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of PE20001019A1 publication Critical patent/PE20001019A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009Sachets, pouches characterised by the material or function of the envelope
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicon Polymers (AREA)
  • Materials For Medical Uses (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

SE REFIERE A UNA MEMBRANA O MATRIZ DESTINADA A CONTROLAR LA PENETRACION DE FARMACOS HECHA DE UN ELASTOMERO BASADO EN SILOXANO. EL ELASTOMERO PUEDE COMPRENDER: i) APROXIMADAMENTE DE 1% A 50% DE GRUPOS 3,3,3-TRIFLUOROPROPILO UNIDOS A LOS ATOMOS DE SILICE DE LAS UNIDADES DE SILOXANO; o ii) UNA MEZCLA DE: a) UN POLIMERO BASADO EN SILOXANO NO SUSTITUIDO CON FLUOR, TAL COMO UN POLI(DIMETILSILOXANO); Y, b) UN POLIMERO, BASADO EN SILOXANO SUSTITUIDO CON FLUOR, TAL COMO UN POLI(DIMETILSILOXANO), DONDE APROXIMADAMENTE 50% DE LOS GRUPOS METILO UNIDOS AL ATOMO DE SILICE DE LAS UNIDADES DE SILOXANO SE HAN SUSTITUIDO CON GRUPOS 3,3,3-TRIFLUOROPROPILO; o iii) UN UNICO POLIMERO BASADO EN SILOXANO RETICULADO, TAL COMO UN POLI(DIALQUIL-SILOXANO) DONDE UNA CIERTA CANTIDAD DE GRUPOS ALQUILO EN LOS ATOMOS DE SILICE ESTAN SUSTITUIDOS CON GRUPOS 3,3,3-TRIFLUOROPROPILO. SE REFIERE TAMBIEN A UN METODO PARA LA PREPARACION DEL ELASTOMERO, QUE CONSISTE EN: I) RETICULAR EN PRESENCIA DE UN CATALIZADOR UN COMPONENTE DE POLISILOXANO CON FUNCIONALIDAD DE VINILO SUSTITUIDO CON 3,3,3-TRIFLUOROPROPILO Y UN AGENTE RETICULANTE CON FUNCIONALIDAD DE HIDRURO DE SILICIO; o II) RETICULAR EN PRESENCIA DE UN CATALIZADOR DE PEROXIDO UN POLISILOXANO SUSTITUIDO CON 3,3,3-TRIFLUOROPROPILO
PE1999001124A 1998-11-12 1999-11-05 Nueva membrana o matriz para controlar la penetracion de farmacos PE20001019A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/190,608 US6056976A (en) 1998-11-12 1998-11-12 Elastomer, its preparation and use

Publications (1)

Publication Number Publication Date
PE20001019A1 true PE20001019A1 (es) 2000-10-12

Family

ID=22702039

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001124A PE20001019A1 (es) 1998-11-12 1999-11-05 Nueva membrana o matriz para controlar la penetracion de farmacos

Country Status (25)

Country Link
US (1) US6056976A (es)
EP (1) EP1151030A1 (es)
JP (1) JP2002530447A (es)
KR (1) KR20010075701A (es)
CN (1) CN1127535C (es)
AR (1) AR025815A1 (es)
AU (1) AU756089B2 (es)
BG (1) BG105499A (es)
BR (1) BR9915325A (es)
CA (1) CA2351091A1 (es)
CZ (1) CZ291399B6 (es)
DE (1) DE1151030T1 (es)
EE (1) EE05528B1 (es)
HK (1) HK1041895B (es)
HU (1) HUP0104380A3 (es)
ID (1) ID29223A (es)
IL (2) IL142525A0 (es)
NO (1) NO20012045L (es)
NZ (1) NZ511215A (es)
PE (1) PE20001019A1 (es)
PL (1) PL348115A1 (es)
RU (1) RU2231531C2 (es)
SK (1) SK5142001A3 (es)
WO (1) WO2000029464A1 (es)
ZA (1) ZA200103297B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214926B1 (en) * 1999-04-01 2001-04-10 Rhodia Inc. Silicone membranes formed without the use of 1-1-1 trichloroethane
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
WO2001085132A1 (en) * 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
US6550480B2 (en) * 2001-01-31 2003-04-22 Numed/Tech Llc Lumen occluders made from thermodynamic materials
EP1438942A1 (en) 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
US20050038183A1 (en) * 2003-08-14 2005-02-17 Dongchan Ahn Silicones having improved surface properties and curable silicone compositions for preparing the silicones
US7045586B2 (en) * 2003-08-14 2006-05-16 Dow Corning Corporation Adhesives having improved chemical resistance and curable silicone compositions for preparing the adhesives
US20050038188A1 (en) * 2003-08-14 2005-02-17 Dongchan Ahn Silicones having improved chemical resistance and curable silicone compositions having improved migration resistance
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20090168013A1 (en) * 2007-12-27 2009-07-02 Kunzler Jay F Trimethylsilyl-Capped Polysiloxane Macromonomers Containing Polar Fluorinated Side-Chains
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
RU2494706C2 (ru) 2008-09-17 2013-10-10 Байер Ой Устройство для введения
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
RU2411077C1 (ru) * 2009-06-09 2011-02-10 Государственное образовательное учреждение высшего профессионального образования "Тверской государственный технический университет" Способ получения оболочек на основе хитозана и солей альгиновой кислоты для микрокапсул, содержащих фосфолипидные мицеллы
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG 18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內用途,包含18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內系統,及其於避孕及婦科治療之用途
JP2015514789A (ja) 2012-04-23 2015-05-21 バイエル・ファルマ・アクチェンゲゼルシャフトBayer Pharma Aktiengesellschaft 過多月経症の処置における18−メチル−15β,16β−メチレン−19−ノル−20−スピロキサ−4−エン−3−オンの使用、ならびに子宮出血障害の処置のための18−メチル−15β,16β−メチレン−19−ノル−20−スピロキサ−4−エン−3−オンを含有する子宮内システム
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
CN105636577A (zh) * 2013-10-18 2016-06-01 拜耳股份有限公司 子宫内递送系统
EP3040388B1 (en) 2014-12-31 2017-08-23 LG Display Co., Ltd. Touch sensitive device comprising electroactive film, display device comprising the same, and method of manufacturing the electroactive film
KR102431597B1 (ko) * 2014-12-31 2022-08-11 엘지디스플레이 주식회사 전기활성 필름을 포함하는 접촉 감응 소자, 이를 포함하는 표시 장치 및 전기활성 필름의 제조 방법
FI3294300T3 (fi) 2015-05-13 2025-03-06 Bayer Oy Pitkävaikutteinen lääkkeenantolaite implantin tai kierukan muodossa, joka käsittää levonorgestreelia ja etinyyliestradiolia
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
EP3727361A4 (en) 2017-12-22 2022-01-12 Alyra Biotech Pty Ltd TREATMENT OF PAIN AND/OR PAIN-RELATED SYMPTOMS RELATED TO DYSMENORRHEA
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
WO2020237325A1 (en) 2019-05-31 2020-12-03 Alyra Biotech Pty Ltd Methods, compositions and devices for treating neuroinflammatory conditions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050492A (en) * 1962-08-21 Degrees of twist at indicated centigrade temperature
US3179619A (en) * 1965-04-20 Xow swell, high temperature organosi- loxane rubbeks containing silicon- bonded fluokjnated aliphatic radicals
US3279996A (en) * 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3661833A (en) * 1970-07-09 1972-05-09 Dow Corning Fast curing organosiloxane resins
US3974120A (en) * 1975-05-05 1976-08-10 General Electric Company Fluorosilicone copolymers and process for the preparation thereof
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
US4525528A (en) * 1983-10-11 1985-06-25 General Electric Company Peroxide-curable fluorosilicone copolymer compositions
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
FR2643572A1 (fr) * 1988-12-22 1990-08-31 Rhone Poulenc Chimie Procede d'encapsulation de particules par pelliculage au moyen d'un copolymere silicone thermoplastique
SE9202250D0 (sv) * 1992-07-29 1992-07-29 Gacell Lab Ab Controlled release morphine preparation
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US5492993A (en) * 1994-02-03 1996-02-20 Dow Corning Corporation Strain-crystallizing poly(methyl(3,3,3-trifluoropropyl)-siloxane) elastomers and methods for making
DE69511180T2 (de) * 1994-06-20 1999-12-23 Dow Corning Corp., Midland Verfahren zur Steuerung der Freisetzung einer Wirksubstanz oder eines Arzneistoffs aus einer Silikongummi-Matrix
US5597384A (en) * 1994-09-13 1997-01-28 Zimmer, Inc. Color coding for implant selection

Also Published As

Publication number Publication date
HUP0104380A3 (en) 2003-04-28
IL142525A (en) 2006-07-05
EE05528B1 (et) 2012-04-16
NZ511215A (en) 2002-04-26
SK5142001A3 (en) 2001-11-06
RU2231531C2 (ru) 2004-06-27
CA2351091A1 (en) 2000-05-25
WO2000029464A1 (en) 2000-05-25
AU1048900A (en) 2000-06-05
CZ291399B6 (cs) 2003-02-12
HUP0104380A2 (hu) 2002-03-28
IL142525A0 (en) 2002-03-10
ID29223A (id) 2001-08-16
NO20012045L (no) 2001-06-28
US6056976A (en) 2000-05-02
KR20010075701A (ko) 2001-08-09
CN1127535C (zh) 2003-11-12
EE200100257A (et) 2002-12-16
AU756089B2 (en) 2003-01-02
BG105499A (bg) 2001-12-29
PL348115A1 (en) 2002-05-06
AR025815A1 (es) 2002-12-18
NO20012045D0 (no) 2001-04-26
HK1041895A1 (en) 2002-07-26
CN1326478A (zh) 2001-12-12
JP2002530447A (ja) 2002-09-17
HK1041895B (zh) 2004-07-23
CZ20011570A3 (cs) 2001-09-12
BR9915325A (pt) 2001-10-09
DE1151030T1 (de) 2002-04-04
EP1151030A1 (en) 2001-11-07
ZA200103297B (en) 2001-10-25

Similar Documents

Publication Publication Date Title
PE20001019A1 (es) Nueva membrana o matriz para controlar la penetracion de farmacos
BR0016697A (pt) Dispositivo para a liberação controlada durante um perìodo de tempo prolongado de uma droga dotada de propriedades antiprogestìnicas
PE31796A1 (es) Composicion para el cuidado del cabello que contiene copolimeros elastomericos termoplasticos injertos
RU2226387C2 (ru) Устройство для доставки лекарственных средств, особенно для доставки прогестинов и эстрогенов
AR001506A1 (es) Composiciones para el tratamiento del cabello.
ES2094192T3 (es) Agentes de contraste constituidos por poli(aldehidos).
CO5060523A1 (es) Una membrana o matriz para controlar la velocidad de penetracion de farmacos
RU2001116121A (ru) Новая мембрана или матрикс для регулируемой проницаемости лекарственных средств
AR036453A1 (es) Composicion cosmetica, su utilizacion, procedimiento de tratamiento de las materias queratinicas, tales como los cabellos y utilizacion de un copolimero entrecruzado de acido metacrilico/acrilato de alquilo c1 - c4.
BRPI0411071A (pt) sistemas de reticulação para polìmeros de hidroxila
BR112018011867A2 (pt) agentes reticulantes vinílicos de policarbonossiloxanos hidrofilizados e usos dos mesmos
PE20001365A1 (es) Dispositivo de suministro de farmacos, especialmente para el suministro de androgenos
ES2140819T3 (es) Polimeros reticulados que contienen fotoiniciadores.
AR036310A1 (es) Un sistema de suministro
KR870008964A (ko) 액체 경화성 폴리오르가노실록산 조성물
KR840008377A (ko) 충진재 존재하의 폴리디오가노실 옥산올리고머의 중합방법
KR880007670A (ko) 자체-접착성 폴리오가노실록산 조성물
AR069552A1 (es) Formulaciones para el tratamiento de semillas y metodos de uso
DK1543065T3 (da) Biomedicinske sammensætninger
BR112017013091A2 (pt) revestimentos de cabo tendo microestruturas projetadas e métodos para fazer revestimentos de cabos tendo microestruturas projetadas
KR880000519A (ko) 유연재료 피복용 중첨가 유기폴리실록산 조성물의 보관시 안정한 수화 에멀션
BR112014019019A8 (pt) Composição de copolímero solúvel ou dispersível, composição desemulsificante, método para separar emulsões e método para produção da dita composição de copolímero
KR910015663A (ko) 실리콘 에멀젼 조성물
ES2069686T3 (es) Reticulacion de prepolimeros de siloxano con funciones (met)acriloxialquenileno.
ATE474019T1 (de) Härtbare silikonzusammensetzung und gehärtetes produkt daraus

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed